Following Massive Loss Last Year, Chinese CRO WuXi PharmaTech Posts Remarkable Rebound During First Quarter Of 2009
This article was originally published in PharmAsia News
Executive Summary
BEIJING - After reporting a devastating $64 million loss for 2008, the leadership of WuXi PharmaTech said that the company had moved back into the black in the first quarter of this year with net income of more than $11 million
You may also be interested in...
China's Leading Medical Equipment Maker Succeeds - Where Others Stumble - In Merging With U.S. Competitor
BEIJING - China's leading developer of medical devices, Mindray Medical International, is emerging as the golden success story in terms of a Chinese enterprise taking over an American competitor in the life sciences arena, with a 15.8 percent jump in net revenues for 2009 to $634.2 million
China's Leading Medical Equipment Maker Succeeds - Where Others Stumble - In Merging With U.S. Competitor
BEIJING - China's leading developer of medical devices, Mindray Medical International, is emerging as the golden success story in terms of a Chinese enterprise taking over an American competitor in the life sciences arena, with a 15.8 percent jump in net revenues for 2009 to $634.2 million
Chinese Medical Device Maker Mindray Reports Global Economic Malaise Will Cap 2009 Earnings
SHANGHAI - Shenzhen-based Mindray Medical International Ltd reported this week that the global financial crisis had cut into the company's earnings growth for the first quarter, and lowered its revenues forecast for 2009 due to the weakened economies of the United States and Europe